Genome Center for Alzheimer’s Disease

Genome Center for Alzheimer’s Disease

The Genome Center for Alzheimer’s Disease represents the Alzheimer’s Disease Sequencing Projects (ADSP) replication phase following up on results from the ADSP discovery analysis. It is funded under an National Institute on Aging cooperative agreement to identify genetic variants that cause, influence risk, or protect against AD, and to identify the underlying genes affected by these variants.

The Genome Center for Alzheimer’s Disease is a five-university effort led by collaborators at the University of Pennsylvania in partnership with the University of Miami, Case Western Reserve University, Boston University, Columbia University and University of Indiana. The University of Miami efforts for GCAD will be co-led by Drs. Pericak-Vance and Eden Martin, Ph.D., director of the Center for Genetic Epidemiology and Statistical Genetics at the HIHG and Professor of human genetics in the Dr. John T. Macdonald Foundation Department of Human Genetics.